Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from ...

President Trump's new executive order has drawn major attention to psychedelic treatments for mental health. Here's what ...

For centuries, healers knew what science is only now confirming: psilocybin is a powerful healing medicine. Could magic ...

The largest review of its kind found no evidence that medicinal cannabis treats depression. Researchers analyzed decades of ...

Researchers from McGill University and Mila, Quebec’s artificial intelligence institute, brought together 89 experts from 17 ...

An international clinical trial led by researchers at the Center for Addiction and Mental Health (CAMH) and University of ...

When Jason Prinzo was diagnosed with depression, he was five years old. His father was an alcoholic and a drug addict who was ...

Experts recommended individualized MDD relapse prevention, including ECT tapering and pharmacotherapy based on risk profiles.

The team behind a New Zealand-developed ketamine tablet has begun the process to get it approved in the US to help people ...

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker ...

A study from Columbia University has brought fresh hope for people struggling with severe depression and suicidal thoughts. The research shows that ketamine, a drug already used in medicine for other ...